As I’m sure many of you saw, the Medtronic 670G hybrid closed-loop system received FDA approval last week, which is a huge accomplishment for artificial pancreas technologies. The 670G system connects a CGM and an insulin pump, and doses insulin based on changes in the blood glucose, as sensed by the CGM.
Personally, I’m super excited for the 670G and can’t wait to see what this breakthrough leads to with other AP technologies. What do you guys think?
More info about the FDA approval of the Medtronic 670G is available here: https://www2.jdrf.org/site/Donation2?18761.donation=form1&df_id=18761&s_src=jdrf.org&s_subsrc=mainMenu.